Amylases for pharmaceutical use

Details for Australian Patent Application No. 2006261444 (hide)

Owner Novozymes A/S Solvay Pharmaceuticals GmbH

Inventors Svendsen, Allan; Gregory, Peter Colin

Agent Shelston IP

Pub. Number AU-A-2006261444

PCT Pub. Number WO2006/136161

Priority PA 2005 00931 24.06.05 DK

Filing date 16 June 2006

Wipo publication date 28 December 2006

International Classifications

A61K 38/47 (2006.01) Medicinal preparations containing peptides

A61K 38/54 (2006.01) Medicinal preparations containing peptides

C12N 9/28 (2006.01) Enzymes, e.g. ligases (6.)

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/136161 Priority application(s): WO2006/136161

2 February 2012 Assignment before Grant

  Novozymes A/S; Solvay Pharmaceuticals GmbH The application has been assigned to Novozymes A/S

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006261445-Tuberculosis vaccines comprising antigens expressed during the latent infection phase

2006261443-Proteases for pharmaceutical use